Cevicogenic headache. Other headache syndromes
Conditions
Interventions
Intervention 1: Group 3 or intervention group: low level laser radiation with wavelength of 810 nm, in pulsed mode, with 11 joules intensity on trigger points of the 3 muscles of the present study. In
Rehabilitation
Group 3 or intervention group: low level laser radiation with wavelength of 810 nm, in pulsed mode, with 11 joules intensity on trigger points of the 3 muscles of the present study.
Group 2 or Sham group: laser probe is placed on the trigger points of the 3 muscles of the present study but the laser device is off and patients do not know that. Patients use their prescription drug
Group 1 or control group: there is no intervention and patients just use their prescription drugs.
Sponsors
Iran University of Medical Sciences, Vice chancellor for research
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with cervicogenic headache (CGH) and between 18 to 40 years old; existence of minimum one trigger point in upper trapezius muscle with or without existence of trigger points in other 2 muscles of the present study; more than 10 degree limitation in cervical flexion and/or rotation to each side. Exclusion criteria: any congenital deformity; long time usage of corticosteroids or anti-inflammatory and anti-analgesic drugs; history of fracture in cervical region; herniated disc; rheumatoid arthritis; pregnancy; history of whiplash injury and neck surgery; any conservative treatment during the last 3 months before starting the present study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of headache. Timepoint: Two weeks Before starting the treatment sessions, before the first treatment session, at the end of treatment session and two weeks after the last treatment session. Method of measurement: Visual analog scale (VAS).;Frequency of headache. Timepoint: Two weeks Before starting the treatment sessions, before the first treatment session, at the end of treatment session and two weeks after the last treatment session. Method of measurement: Number of headache during one week.;Active cervical flexion range of motion. Timepoint: Two weeks Before starting the treatment sessions, before the first treatment session, at the end of treatment session and two weeks after the last treatment session. Method of measurement: CROM device.;Active cervical rotation range of motion to left and right. Timepoint: Two weeks Before starting the treatment sessions, before the first treatment session, at the end of treatment session and two weeks after the last treatment session. Method of measurement: CROM device (degree).;Pain threshold. Timepoint: Two weeks Before starting the treatment sessions, before the first treatment session, at the end of treatment session and two weeks after the last treatment session. Method of measurement: By an algometer (algometry).;Quality of life. Timepoint: Two weeks Before starting the treatment sessions, before the first treatment session, at the end of treatment session and two weeks after the last treatment session. Method of measurement: Headache diability index (HDI) questionnaire. | — |
Countries
Afghanistan
Contacts
Public ContactJavad Sarrafzadeh
School of Rehabilitation Sciences, Iran University of Medical Sciences
Outcome results
None listed